Not Yet Enrolling

A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943

The main purpose of the study is to look at the effect of the study drug compared to placebo on calorie intake, energy metabolism, and appetite.

Trial Summary

Age Range
18 - 60 years
Conditions the trial is for
Obesity
What the trial is testing?
retatrutide
Could I receive a Placebo?
Yes
Enrollment Goal
74
Trial Dates
Mar 18, 2024 - Jul 2025
How long will I be in the trial?
The study will last up to 6 months and may include up to 20 visits.
Trial Phase
I

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Have obesity or overweight

  • Have tried and failed at least one weight loss diet

Participants Must Not:

  • Have Type 1 or Type 2 Diabetes

  • Have change in body weight of greater than 5 kg (11 pounds) within 3 months prior to start of study

  • Have acute or chronic liver disease

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Clinical Trial Resources